Letter to the Editor: “Progesterone Is Important for Transgender Women’s Therapy—Applying Evidence for the Benefits of Progesterone in Ciswomen”-Reference-Cited by-同舟云学术

Letter to the Editor: “Progesterone Is Important for Transgender Women’s Therapy—Applying Evidence for the Benefits of Progesterone in Ciswomen”

Published:2019-03-12 Issue:8 Volume:104 Page:3127-3128
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Iwamoto Sean J¹²³^ORCID,T’Sjoen Guy⁴^ORCID,Safer Joshua D⁵^ORCID,Davidge-Pitts Caroline J⁶,Wierman Margaret E¹²,Glodowski Michele B⁷^ORCID,Rothman Micol S¹³

Affiliation:

1. Division of Endocrinology, Metabolism & Diabetes, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado

2. Division of Endocrinology, Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado

3. UCHealth Integrated Transgender Program, UCHealth University of Colorado Hospital, Aurora, Colorado

4. Department of Endocrinology and Center for Sexology and Gender, Ghent University Hospital, Ghent, Belgium

5. Center for Transgender Medicine and Surgery, Mount Sinai Health System and Icahn School of Medicine at Mount Sinai, New York, New York

6. Division of Endocrinology, Metabolism and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota

7. Division of Endocrinology, Diabetes and Metabolism, New York University School of Medicine, New York, New York

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/104/8/3127/28832310/jc.2019-00249.pdf

Reference8 articles.

1. Progesterone is important for transgender women’s therapy—applying evidence for the benefits of progesterone in ciswomen;Prior;J Clin Endocrinol Metab,2019

2. Clinical review: breast development in trans women receiving cross-sex hormones;Wierckx;J Sex Med,2014

3. Estrogen-progestin therapy causes a greater increase in spinal bone mineral density than estrogen therapy - a systematic review and meta-analysis of controlled trials with direct randomization;Prior;J Musculoskelet Neuronal Interact,2017

4. Bone safety during the first ten years of gender-affirming hormonal treatment in transwomen and transmen;Wiepjes,2019

5. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials;Manson;JAMA,2013

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia;Internal Medicine Journal;2024-07-26

2. Pain mechanisms in the transgender individual: a review;Frontiers in Pain Research;2024-03-27

3. Effects of gender affirming hormone treatment in transgender individuals – a retrospective cohort study;Endocrine;2024-02-22

4. Approach to the Patient: Hormonal Therapy in Transgender Adults With Complex Medical Histories;The Journal of Clinical Endocrinology & Metabolism;2023-09-08

5. Gender-affirming hormonal therapy for transgender and gender-diverse people—A narrative review;Best Practice & Research Clinical Obstetrics & Gynaecology;2023-02